Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Shenxiong Dropping Pills in Coronary Artery Disease Angina (Qi Deficiency and Blood Stasis)
CTR20171229Phase 2Completed
- Sponsor
- Guilin Eight Plus One Pharmaceutical Research
- Start
- Oct 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Compound Shenxiong Dripping Pills in coronary arteriosclerosis, stable angina, sponsored by Guilin Eight Plus One Pharmaceutical Research. Started Oct 2017; status: completed.
02
Drugs
Compound Shenxiong Dripping Pills
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on CTR20171229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171229.